Company performance
Add to research
Current Price
as of Feb 05, 2025$4.46
P/E Ratio
N/A
Market Cap
$21.54M
Description
Add to research
Senti Biosciences, Inc. is a biotechnology company. It engages in the business of developing next-generation cell and gene therapies engineered with a gene circuit platform technology to fight challenging diseases. The company was founded by Timothy K. Lu, Wilson Wong, and Philip Lee on June 9, 2016 and is headquartered in South San Francisco, CA.
Metrics
Add to research
Overview
- HQSouth San Francisco, CA
- SectorHealth Technology
- IndustryBiotechnology
- TickerSNTI
- Price$4.46+15.54%
Trading Information
- Market cap$21.54M
- Float62.61%
- Average Daily Volume (1m)67,847
- Average Daily Volume (3m)2,423,965
- EPS-$15.60
Company
- RevenueN/A
- Rev growth (1yr)-100.00%
- Net income-$28.87M
- Gross marginN/A
- EBITDA marginN/A
- EBITDA-$13.44M
- EV$34.57M
- EV/RevenueN/A
- P/EN/A
- P/SN/A
- P/B1.28
Documents
Add to research
SEC Filings
Factset Street Account